Skip to main content
Clinical Trials/IRCT20220924056025N1
IRCT20220924056025N1
Not yet recruiting
Phase 3

Investigating the effect of methylphenidate on increasing the level of consciousness of patients with hypoxic ischemic encephalopathy in the special care departments of Bo Ali Qazvin Hospital during one year.

Qazvin Medical Sciences Research Deputy0 sites48 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Qazvin Medical Sciences Research Deputy
Enrollment
48
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Qazvin Medical Sciences Research Deputy

Eligibility Criteria

Inclusion Criteria

  • Patients hospitalized in the intensive care unit with the diagnosis of HIE hypoxic ischemic encephalopathy,
  • Aged between 18 and 65 years
  • Both sexes (male and female)
  • With some degree of reduced level of consciousness.

Exclusion Criteria

  • Patients with a history of epilepsy
  • Patients with high blood pressure that is newly discovered and not treated or controlled
  • Patients with Cardiac ischemia and arrhythmia that are newly discovered and not treated or controlled,
  • Patients with deafness
  • Patients with rapid changes in vital signs and unstable hemodynamics
  • Patients with multiple organ failure
  • Patients with hyperthyroidism
  • Drug addiction
  • Secondary surgery
  • Reluctance to attend the investigation based on the opinion of the patient's legal guardian

Outcomes

Primary Outcomes

Not specified

Similar Trials